You have been chosen to receive this valuable information.
 
A SPECIAL
ANNOUNCEMENT FROM:
  PE Logo  
Banner Image

Do your patient services align with your commercial objectives?

After completing the rigorous processes of product development and regulatory approvals, commercializing your new pharmaceutical or medical technology should be relatively straightforward and uncomplicated. Unfortunately, that's usually not the case; there is no one-size-fits-all program template.

A successful product commercialization program aligns the right services to the right patients in the right target market with the right messaging – and evaluates each of these factors to be sure the program components are working. Thoughtful consideration and planning need be given to driving patient access and uptake – compliantly. As such, manufacturers should view each new product launch as a unique event and create a program specific to the drug or device, especially with respect to the patient and provider journeys. Here are few key points to think of:

how to determine the level of support services required for a new product launch,
what are the considerations for setting up those support services, and
how to overcome program hurdles compliantly.

We share examples of common commercialization missteps along with examples of high- and low-touch support services.

LEARN MORE HERE
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, a MMH Group Publication. You are on the mailing list as %%emailaddress%%.